NCT07867730

Brief Summary

Restrictive lung diseases (RLD) represent a significant cause of morbidity, often necessitating intensive interventions such as mechanical ventilation due to diminished lung compliance (LC) and reduced total lung capacity (TLC). Mechanical ventilation, while vital, is associated with ventilator-induced diaphragmatic dysfunction (VIDD), leading to rapid muscle atrophy and impeding patient recovery. This proposed study aims to evaluate the clinical impact of IMT and PEP on improving respiratory muscle strength, lung compliance and mobilizing secretions (effective cough reflex) in patients with RLD who require mechanical ventilation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Dec 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Dec 2025Jan 2027

Study Start

First participant enrolled

December 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

1.2 years

First QC Date

July 9, 2026

Last Update Submit

October 7, 2026

Conditions

Keywords

restrictive lung diseasesinterstitial lung diseasesidiopathic lung fibrosisinspiratory muscle trainingPEP devicesmechanical ventilationVentilator induced diaphragm dysfunction

Outcome Measures

Primary Outcomes (1)

  • Lung compliance

    It will be assessed daily using ventilator-derived parameters. Static and dynamic compliance values will be recorded directly from the ventilator settings, providing objective measures of lung mechanics improvements throughout the intervention period.

    From randomization until extubation, or completion of the 7-day intervention period, whichever occurs first; assessed twice daily, up to 7 days

Study Arms (2)

Conventional Physiotherapy

ACTIVE COMPARATOR

Participants in the group A will recieve standard physiotherapy, including passive/active limb exercises, chest percussion, and positioning. Each session will last for 15 minutes.

Other: Conventional Chest Physical Therapy

Conventional Physiotherapy Plus Inspiratory Muscle Training and Positive Expiratory Pressure

EXPERIMENTAL

Participants in Group B will recieve standard physiotherapy along with targeted inspiratory and positive expiratory pressure (PEP) muscle training to enhance respiratory muscle strength.

Device: Inspiratory muscle training

Interventions

Inspiratory Muscle Training (IMT): Patients will be positioned at a 45° angle in bed. The IMT device will be individually calibrated and connected to the endotracheal tube. Initial intensity will be set at 40% of the patient's maximal inspiratory pressure (MIP), progressing daily by 10%. Positive Expiratory Pressure (PEP) Training: Patients will be positioned laterally. The PEP device will be set at 7 cm H₂O resistance and will be connected to the endotracheal tube. Training will continue daily. Sessions will be paused if signs of respiratory or hemodynamic instability appear (e.g., altered respiratory rate, SpO₂, BP, HR, mental status, hemoptysis, arrhythmias, or diaphoresis). In such cases, training intensity will be maintained at the previous level.

Conventional Physiotherapy Plus Inspiratory Muscle Training and Positive Expiratory Pressure

Participants will receive standard physiotherapy consisting of passive and active range-of-motion exercises for the upper and lower limbs, chest physiotherapy (including chest percussion), and therapeutic positioning. Each treatment session will last 15 minutes and will be administered by a qualified physiotherapist according to the institutional standard of care.

Conventional Physiotherapy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged between 18 and 60 years.
  • Diagnosed with restrictive lung disease (RLD), including interstitial lung diseases, idiopathic pulmonary fibrosis, chest wall deformities, or neuromuscular diseases.
  • Admitted to the ICU and requiring invasive mechanical ventilation for more than 48 hours.
  • Glasgow Coma Scale score over 13, inspiratory pressures below -20 cmH2O, oxygen saturation above 90%, tidal volumes exceeding 5ml/kg, respiratory rates under 35 breaths per minute
  • Hemodynamically stable at the time of enrolment (as determined by the treating physician).

You may not qualify if:

  • Pre-existing chronic obstructive pulmonary disease (COPD) or other primary obstructive pathologies.
  • Hemodynamic instability (e.g., requiring high-dose vasopressors).
  • Active pneumothorax or untreated bronchopleural fistula.
  • History of cranial or facial trauma, recent thoracic or abdominal surgery contraindicating the intervention.
  • Pre-existing cognitive impairment or inability to comprehend and cooperate with the training protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Foundation University College of Physical Therapy Islamabad

Islamabad, Pakistan

RECRUITING

Foundation University College of Physical Therapy Islamabad

Rawalpindi, Pakistan

RECRUITING

Foundation University College of Physical Therapy Islamabad

Rawalpindi, Pakistan

RECRUITING

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Central Study Contacts

Syeda Sumaira Batool, MS-CPPT

CONTACT

Qurat Ul Ain Khalid, MS-MSKPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial having two groups. One group (interventional group) will receive standard physiotherapy along with targeted inspiratory and positive expiratory pressure (PEP) muscle training to enhance respiratory muscle strength. The control group will recieve standard physiotherapy, including passive/active limb exercises, chest percussion, and positioning. Each session will last for 15 minutes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2026

First Posted

October 9, 2026

Study Start

December 1, 2025

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

January 31, 2027

Last Updated

October 9, 2026

Record last verified: 2026-10

Locations